Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children

NCT02674607 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT02674607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02674607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2015
Completion date
October 31, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

beta thalassemia major